RISE: Reducing Cancer and HIV Stigma Through Empowerment

NCT07728370 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2026-07-27

No results posted yet for this study

Summary

This multilevel randomized behavioral study evaluates participant- and provider-level stigma-reduction interventions in Zambia. Participant-level intervention: Women living with cervical cancer and HIV (WLC+H ) are randomized in a 2×2 factorial design of storytelling versus neutral videos and storytelling versus neutral disclosure interventions to assess effects on quality of life, anxiety, and depressive symptoms. Provider-level intervention: Healthcare workers are randomized to storytelling or neutral videos to assess changes in stigma and compassion. The study also evaluates participant -reported stigma and satisfaction with care before and after implementation of the provider intervention.

Conditions

  • HIV
  • Cervical Cancer Stigma

Interventions

BEHAVIORAL

Neutral Video

Participants in the control group will watch neutral videos and describe objective, non-emotional objects/events

BEHAVIORAL

Storytelling

The storytelling intervention group will watch the storytelling videos and then describe objective, non-emotional objects/events.

BEHAVIORAL

Self disclosure

Participants will watch neutral videos and then talk/write about their cancer/HIV-related experiences to themselves.

BEHAVIORAL

Combination

The combination group will watch the storytelling videos and then talk/write about their cancer/HIV-related experiences to themselves.

BEHAVIORAL

Video

Participants (healthcare workers) will watch storytelling videos in a group setting, followed by a facilitated discussion and role-playing to enhance empathy and understanding.

BEHAVIORAL

Waitlist

Participants will watch unrelated presentations in a group setting while on a waitlist. They will receive the intervention after completing the post-test.

Sponsors & Collaborators

  • Cancer Diseases Hospital; University of Zambia

    collaborator UNKNOWN
  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Qian Lu, MD, PHD · UT MD Anderson

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2030-05-31
Completion
2030-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07728370 on ClinicalTrials.gov